A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer

from Cancer via ola Kala on Inoreader http://ift.tt/1TxuvLM
via IFTTT